PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-24

  1. 9,839 Posts.
    lightbulb Created with Sketch. 1258
    Lol it's old data.

    Your interpretation is baseless and not linked to FDA requested staged approach to find min effective dose
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.